
S1-E1.2 – NAFLD Prevalence and Type 2 Diabetes in an Endocrinology Clinic: The Need for Screening and Vigilance
Fatty Liver Researcher and endocrinology key opinion leader Ken Cusi discusses the high levels of NAFLD prevalence and fibrosis among Type 2 Diabetes Mellitus patients and the value of early screening, particularly in endocrinology clinics, where the percent of patients with NAFLD and NASH fibrosis is double what we find in primary care.